FDA seeks public input on cannabis-derived products in vet medFebruary 3, 2025The U.S. Food and Drug Administration (FDA)’s Center for Veterinary Medicine aims to get information on overall trends related to these products, including adverse effects, safety issues, and toxicological risks.
SPONSORED CONTENTLife Gets Busy, Stay ON POINT With Cytopoint®Simplify your approach to allergic pruritus with Cytopoint. Help maintain control of allergic itch when schedules get hectic for both veterinarians and pet owners alike. + Learn more
Efficacy of cannabinoids in veterinary medicineMay 8, 2024Although the use of cannabinoids, particularly CBD-rich hemp products, is in its infancy in veterinary medicine, there appears to be optimism regarding its utilization concurrently with other therapeutics for a range of disorders, including epileptic seizure control, pain associated with osteoarthritis, and atopic dermatitis.
Cannabinoids: It's all about the petNovember 6, 2023The use of cannabinoids in veterinary medicine is growing. What is less clear is the treatment across veterinary species, and the first necessary step into the use of cannabidiol (CBD) and cannabidiolic acid (CBDA) is to assess the pharmacokinetics in the species of intent.
